Preemptive T-Rapa Cell DLI after Low Intensity Allogeneic HCT May Allow for Improved Overall Survival in High Risk Lymphoid Malignancies  David Halverson, MD, Scott Rowley, MD, Michael R. Bishop, MD, Brenna Hansen, RN, Stephanie Cotton, RN, Bazetta Blacklock Schuver, RN, Seth M. Steinberg, PhD, Fran T. Hakim, PhD, Juan Gea-Banacloche, MD, Nancy Hardy, MD, Claude Sportes, MD, Steven Z. Pavletic, MD, Hanh Khuu, MD, David F. Stroncek, MD, Bruce L. Levine, PhD, Carl H. June, MD, Michele L. Donato, MD, Andre Goy, MD, Andrew Pecora, MD, Ronald Gress, MD, Daniel Fowler, MD  Biology of Blood and Marrow Transplantation  Volume 22, Issue 3, Pages S139-S140 (March 2016) DOI: 10.1016/j.bbmt.2015.11.478 Copyright © 2016 Terms and Conditions

Figure 1 Biology of Blood and Marrow Transplantation 2016 22, S139-S140DOI: (10.1016/j.bbmt.2015.11.478) Copyright © 2016 Terms and Conditions